Related Experiment Video
Updated: Jun 4, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
CE-MS in biomarker discovery, validation, and clinical application
Harald Mischak1, Joost P Schanstra
1Mosaiques Diagnostics & Therapeutics, Hannover, Germany.
Proteomics. Clinical Applications
|February 1, 2011
Summary
Capillary electrophoresis coupled with mass spectrometry (CE-MS) is a powerful tool for identifying disease biomarker peptides in clinical proteomics. This review highlights CE-MS advancements and applications in biomarker discovery and clinical diagnostics.
Area of Science:
- Proteomics and Clinical Diagnostics
Background:
- Capillary electrophoresis coupled with mass spectrometry (CE-MS) is increasingly utilized in proteome analysis.
- Focus is on identifying biomarker peptides for clinical proteomics and disease diagnosis.
Purpose of the Study:
- To review technical aspects and recent improvements in CE-MS coupling.
- To evaluate the merits and challenges of CE-MS for biomarker discovery in body fluids.
- To discuss successful applications and future directions of CE-MS in clinical proteomics.
Main Methods:
- Review of technical advancements in CE-MS coupling.
- Analysis of CE-MS applications in biomarker discovery from body fluids.
- Discussion of theoretical and practical obstacles in proteomic analysis.
Main Results:
- CE-MS shows significant promise for biomarker discovery in clinical proteomics.
- Several successful applications of CE-MS for biomarker identification are presented.
- The review details implications for disease diagnosis, prognosis, and therapy evaluation.
Conclusions:
- CE-MS is a valuable technology for biomarker discovery and clinical applications.
- Addressing current challenges in CE-MS analysis of body fluids is crucial for future improvements.
- Continued development of CE-MS will enhance its role in personalized medicine.
